Home › Research › Getting a diagnosis
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort
Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB.. Archives of neurology, 2000-06-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objectives To relate performance on tests of cognitive ability to the subsequent development of probable Alzheimer disease (pAD) and to identify the pattern of earliest changes in cognitive functioning associated with a diagnosis of pAD. Design From May 1975 to November 1979, a screening neuropsychological battery was administered to Framingham Study participants. They were followed up prospectively for 22 years and examined at least every 2 years for the development of pAD. Setting A community-based center for epidemiological research. Participants Subjects were 1076 participants of the Framingham Study aged 65 to 94 years who were free of dementia and stroke at baseline (initial) neuropsychological testing. Main outcome measure Presence or absence of pAD during a 22-year surveillance period was related to test performance at initial neuropsychological testing. Results Lower scores for measures of new learning, recall, retention, and abstract reasoning obtained during a dementia-free period were associated with the development of pAD. Lower scores for measures of abstract reasoning and retention predicted pAD after a dementia-free period of 10 years. Conclusions The "preclinical phase" of detectable lowering of cognitive functioning precedes the appearance of pAD by many years. Measures of retention of information and abstract reasoning are among the strongest predictors of pAD when the interval between initial assessment and the development of pAD is long. Arch Neurol. 2000.
What this study adds
Evidence grade: Low
This is a trial of 1,076 participants. Retention and abstract reasoning still predicted it after 10 dementia-free years, which led the authors to conclude that a "preclinical phase" of lowered cognitive functioning precedes diagnosis "by many years". These are group-level associations: the record gives no test cut-offs or individual risk figures, so a single low score does not diagnose anyone.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., & D'Agostino, R. B. (2000). The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Archives of neurology. https://doi.org/10.1001/archneur.57.6.808
Vancouver
Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Archives of neurology. 2000. doi:10.1001/archneur.57.6.808. PMID: 10867777.
BibTeX
@article{elias2000-10867777,
author = {Elias, M. F. and Beiser, A. and Wolf, P. A. and Au, R. and White, R. F. and D'Agostino, R. B.},
title = {{The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort}},
journal = {Archives of neurology},
year = {2000},
doi = {10.1001/archneur.57.6.808},
pmid = {10867777},
url = {https://doi.org/10.1001/archneur.57.6.808}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Objectives To relate performance on tests of cognitive ability to the subsequent development of probable Alzheimer disease (pAD) and to identify the pattern of earliest changes in cognitive functioning associated with a diagnosis of pAD.
- Results Lower scores for measures of new learning, recall, retention, and abstract reasoning obtained during a dementia-free period were associated with the development of pAD.
Why it matters
In 1,076 Framingham Study participants aged 65 to 94, who were free of dementia and stroke when tested in 1975–79 and then followed for 22 years, lower scores on tests of new learning, recall, retention and abstract reasoning were associated with later developing probable Alzheimer's disease. Retention and abstract reasoning still predicted it after 10 dementia-free years, which led the authors to conclude that a "preclinical phase" of lowered cognitive functioning precedes diagnosis "by many years". These are group-level associations: the record gives no test cut-offs or individual risk figures, so a single low score does not diagnose anyone.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Participants1,076
- Evidence strengthLow
How this study scored 55/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2000 — older than 20 years, still counted |
| Sample size | 3 / 4 | 1,076 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 723 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 25.8 citations a year over 28 year(s) since 2000 |
| Impact for its field and year | 4 / 6 | Cited 17.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 56 other studies in this library |
| Still being cited | 2 / 4 | Cited 28 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Ralph B. D’Agostino: h-index 237 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Boston University: institution h-index 1,456 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 10867777) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
56 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Getting a diagnosis from nearby years
Also in Getting a diagnosis
141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.